Skip to main content
Premium Trial:

Request an Annual Quote

John Fenn Dies

John Fenn, who won the Nobel Prize in chemistry in 2002, died, reports The New York Times. He was 93. While he was at Yale University, Fenn developed electrospray ionization as a way to speed up protein analysis. He then tussled with the school over patent rights to electrospray ionization — Fenn personally patented it and then licensed it to a company he started, and Yale took him to court where Fenn was found guilty of "civil theft." Fenn then moved to Virginia Commonwealth University. "John Fenn was one of those scientists whose discovery opened up an entirely new field to investigation; in his case, proteomics — the hallmark science of the post-genomic era," says Thomas Huff, a vice provost at VCU, in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.